FDA arranges Feb. 26 AdComm to discuss J&J COVID-19 vaccine EUA

FDA arranges Feb. 26 AdComm to discuss J&J COVID-19 vaccine EUA

Source: 
Fierce Biotech
snippet: 

Johnson & Johnson has filed for emergency FDA authorization of its one-dose COVID-19 vaccine. The FDA has scheduled an advisory committee meeting to discuss the application for Feb. 26.